Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-01-04 @ 8:58 AM
Study NCT ID:
NCT01573767
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2012-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-08
First Submit QC Date:
None
Study First Post Date:
2012-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-18
Results First Submit QC Date:
None
Results First Post Date:
2015-04-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-18
Last Update Post Date:
2017-01-09
Last Update Post Date Type:
ESTIMATED